| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Marketing > Determining Marketing Effectiveness Even If You Didn't Track |
|
Digg It - Determining Marketing Effectiveness Even If You Didn't Track
What if you've done a variety of marketing activities over the past year, but you did not establish any way to track the According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product response? Now you don’t know what worked and what didn’t. Is there anything you can do now before you continue with yo ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ur marketing efforts and potentially continue spending money on not-so-effective marketing activities? First of all, do lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. n’t beat yourself up. You are not alone. In fact, one of my biggest challenges as a marketing consultant has been to get here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe my clients to track the effectiveness of their various marketing activities. The first thing to do is recognize the im d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro portance of tracking, and make sure that you have a plan in place to track all of your future marketing activities. The ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc simplest way to track is to ask each new customer where or how they found out about you. You may also want to consider easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ncluding a code on any flyers or brochures that you distribute, and providing a reason for the customer to bring that fl nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically yer in when they come to make a purchase. Reasons to return the flyer could be to take advantage of a special offer, or and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ to get a discount or free bonus gift. You can also do this by phone or on the Internet if that is how your customers ma ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ke purchases. Simply ask them to provide you with the code on the brochure or flyer that they are calling or ordering fr ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a om. Make sure the code is specific to the location or group of people that you distributed the flyer to. If you are net dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod working or speaking to a group and someone gives you their business card and agrees to receive your free report or e-new cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin sletter, make sure you include a reference in your contact database of the event where you met them. As far as tracking tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen your past marketing activities, consider asking your current customers how they found out about you. You could do a sur t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel vey that includes a number of customer satisfaction questions, but also includes a question to determine how they found ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust out about you. If you have a handful of clients that you work closely with and you really don’t know how they found you y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products , pick up the phone and ask them. Either of these tactics should give you an idea of what marketing activities worked a . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de nd which ones you may be able to do without in the future. If you're still not sure, continue with all the marketing ac elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip tivities, BUT put tracking mechanisms into place so you won't end up in the same boat next year. (C) 2005 Debbie LaChus tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Your Options For Teaching Courses
|